Skip to content

AnaptysBio

US · ANAB #3010 by market cap Listed 2017
46.63 -0.77 -1.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 17 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.0 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
110.50% +1.01pp
Institutions
278 +17
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund50.45%
Hedge Fund47.36%
Public Company7.61%
Individual/Insider2.33%
VC/PE Fund2.26%
Insurance Company1.14%
Private Company0.81%
Government Pension Fund0.51%
Endowment Fund0.30%

Top holders as of 2026-06-30

EcoR1 Capital, LLC 26.36% · 7.88M sh
BlackRock 6.33% · 1.89M sh
Sirenia Capital Management LP 4.99% · 1.49M sh
Tang Capital Management, LLC 4.45% · 1.33M sh
State Street Global Advisors 3.83% · 1.15M sh
Vanguard Capital Management, LLC 3.04% · 909.95K sh
Affinity Asset Advisors, LLC 2.76% · 826.11K sh
Sanofi 2.75% · 821.92K sh
Millennium Management LLC 2.70% · 807.32K sh
Woodline Partners LP 2.40% · 717.01K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 14 buys · 36 sells

NameRoleStake
EcoR1 Capital, LLC -- 26.36%
Daniel Faga Chief Executive Officer 1.66%
John Schmid Independent Director 0.13%
Paul Lizzul Former Chief Medical Officer 0.14%
John Orwin Independent Director 0.06%
Eric Loumeau Former Chief Legal Officer 0.04%
Rita Jain Former Independent Director 0.04%
Hollings Renton Lead Independent Director 0.04%
Magda Marquet Former Independent Director 0.03%
Dennis Fenton Former Independent Director 0.02%
Dennis Mulroy Former Chief Financial Officer --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Hollings Renton Lead Independent Director Derivative Exercise and Sale -5,000 $18.03–49.87
2026-09-14 John Orwin Independent Director Derivative Exercise and Retained +1,300 --
2026-06-28 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -9,476 $63.45
2026-06-25 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -10,000 $60.82
2026-06-16 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -850 $60.00
2026-06-15 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -1,265 $60.00
2026-06-14 John Orwin Independent Director Derivative Exercise and Retained +6,030 --
2026-06-14 Hollings Renton Lead Independent Director Derivative Exercise and Retained +6,030 --
2026-06-14 John Schmid Independent Director Derivative Exercise and Retained +6,030 --
2026-06-14 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $57.65
2026-06-11 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $55.30
2026-06-10 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -35,000 $52.82
2026-06-09 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $52.33
2026-06-08 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $51.61
2026-06-07 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -21,987 $50.83
2026-06-04 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -22,491 $51.29
2026-06-03 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $51.77
2026-06-02 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $50.86
2026-06-01 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -20,000 $51.65
2026-05-31 Dennis Mulroy Former Chief Financial Officer Intent to Sell (Form 144) -7,691 $52.57

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AnaptysBio discussion 0 comments

Add a comment